Multiple Sclerosis Disease-Modifying Therapy Prescribing Patterns in Ontario
نویسندگان
چکیده
منابع مشابه
Multiple sclerosis disease-modifying therapy prescribing patterns in Ontario.
BACKGROUND Differences in Multiple sclerosis (MS) disease-modifying therapy (DMT) prescribing patterns between different groups of neurologists have not been explored. OBJECTIVE To examine concentrations of prescribing patterns and to assess if MS-specialists use a broader range of DMTs relative to general neurologists. METHODS We conducted a cross-sectional study using administrative claim...
متن کاملDisease Modifying Therapy in Multiple Sclerosis
Multiple sclerosis is an autoimmune disease of the central nervous system characterized by inflammatory demyelination and axonal degeneration. It is the commonest cause of permanent disability in young adults. Environmental and genetic factors have been suggested in its etiology. Currently available disease modifying drugs are only effective in controlling inflammation but not prevention of neu...
متن کاملAssessment of treatment patterns associated with injectable disease-modifying therapy among relapsing–remitting multiple sclerosis patients
BACKGROUND Availability of oral disease-modifying therapy (DMT) for relapsing-remitting multiple sclerosis (RRMS) may affect injectable DMT (iDMT) treatment patterns. OBJECTIVE The objective of this paper is to evaluate iDMT persistency, reasons for persistency lapses, and outcomes among newly diagnosed RRMS patients. METHODS Medical records of 300 RRMS patients initiated on iDMT between 20...
متن کاملAssociation of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
To cite: Scolding N, Barnes D, Cader S, et al. Pract Neurol 2015;15:273–279. INTRODUCTION In June 1999, the Association of British Neurologists (ABN) first published guidelines for the use of the licensed multiple sclerosis (MS) disease-modifying treatments (at that time β-interferon and glatiramer acetate). The guidelines were revised in 2001 and have been periodically updated since then. In 2...
متن کاملNon-adherence to Disease-Modifying Treatments in Patients with Multiple Sclerosis
Background: Multiple Sclerosis (MS) is a debilitating disease of the central nervous system. Usually, long-term MS medications are injected intramuscularly or subcutaneously, making them intolerable for many MS patients. Objectives: In the present study, the rate and the causes of non-adherence to MS disease-modifying drugs (DMDs) were assessed in patients with MS. Materials and Methods: Two ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
سال: 2013
ISSN: 0317-1671,2057-0155
DOI: 10.1017/s031716710001297x